GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tsubota Laboratory Inc (TSE:4890) » Definitions » Net Income From Continuing Operations

Tsubota Laboratory (TSE:4890) Net Income From Continuing Operations : 円-641.3 Mil (TTM As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Tsubota Laboratory Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Tsubota Laboratory's net income from continuing operations for the three months ended in Dec. 2023 was 円-662.1 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Dec. 2023 was 円-641.3 Mil.

Tsubota Laboratory Net Income From Continuing Operations Historical Data

The historical data trend for Tsubota Laboratory's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tsubota Laboratory Net Income From Continuing Operations Chart

Tsubota Laboratory Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Net Income From Continuing Operations
3.69 255.84 202.34 144.22 -636.37

Tsubota Laboratory Quarterly Data
Mar20 Mar21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -111.40 -124.70 -168.70 -662.08 314.16

Tsubota Laboratory Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-641.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tsubota Laboratory (TSE:4890) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tsubota Laboratory Inc (TSE:4890) » Definitions » Net Income From Continuing Operations
Comparable Companies
TSE:7777 TSE:3079 TSE:7792 TSE:5187 TSE:7963 TSE:7707 TSE:4889 TSE:7600 TSE:6678 TSE:5212 ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
N/A
Address
34 Shinanomachi, 304 Toshin Shinanomachi-ekimae Building, Shinjuku-ku, Tokyo, JPN, 160-0016
Website
https://tsubota-lab.com
Tsubota Laboratory Inc is engaged in the research and development of pharmaceuticals and medical devices for the treatment of myopia, dry eyes, and presbyopia.

Tsubota Laboratory (TSE:4890) Headlines

No Headlines